Focal encephalopathy following methotrexate therapy. Administration via a misplaced intraventricular catheter.
Two patients with lymphoreticular malignant neoplasms and leptomeningeal tumor spread were treated with intraventricular administration of methotrexate via an Ommaya reservoir. The intraventricular instillation of methotrexate resulted in focal CNS damage in brain parenchyma inadvertently pierced by the shunt. Disorientation, aphasia, and right hemiparesis developed in both patients. Computed tomography disclosed a contrast-enhancing, low-density mass in the left cerebral cortex where the distal shunt tip was lodged. In one case the lesion was pathologically consistent with chronic inflammation. A lesion occurred in one patient despite repositioning of the shunt prior to methotrexate instillation. Shunt removal and administration of systemic corticosteroids resulted in resolution of symptoms in one patient.
D000293:Adolescent; D000328:Adult; D001927:Brain Diseases / Q000139:chemically induced*; D001930:Brain Injuries / Q000209:etiology*; D002404:Catheterization / Q000009:adverse effects*; D006801:Humans; D007276:Injections, Intraventricular / Q000009:adverse effects*; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects*
D008727:Methotrexate